Cancer stem cell markers: premises and prospects

Area of Science:

• Oncology
• Cancer Biology
• Stem Cell Research

Background:

• Cancer stem cells (CSCs) are implicated in therapeutic resistance and tumor recurrence.
• Conventional chemotherapy targets rapidly dividing cells, often sparing slow-cycling CSCs.
• CSCs are recognized as key drivers of malignancy and metastasis.

Purpose of the Study:

• To review CSC markers across various cancer types.
• To highlight the significance of CSC biomarkers in targeted therapy.
• To discuss therapeutic implications for preventing cancer invasion and metastasis.

Main Methods:

• Literature review of studies on cancer stem cells and biomarkers.
• Analysis of CSC marker expression in different malignancies.
• Discussion of therapeutic strategies targeting CSCs.

Main Results:

• CSC markers are crucial for identifying cancer-initiating cells.
• Targeting CSCs offers a promising strategy to overcome chemotherapy resistance.
• Biomarker-guided therapies can potentially prevent cancer spread.

Conclusions:

• Selective targeting of CSCs using biomarkers is essential for effective cancer treatment.
• Understanding CSC biology is critical for developing novel anti-cancer therapies.
• Biomarker-based approaches hold promise for reducing cancer relapse and metastasis.